Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | group enriched outside the brain (platelets) | 0.10 |
| chemistry Open Targets | a small-molecule pocket: anfibatide | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 189 | 0.91 |
| pathways Reactome | 10 pathways; mostly other | 0.30 |
No case: the score is under the bar. Receipt 8795
Sealed predictions
- GP1BA in dopamine neurons, braak-0.57 (p 0.108) → -0.65 (p 0.060)receipt 8801
Swarm cases
receipt 8801: GP1BA in dopamine neurons, braak
- power
- full sample -0.66 (p 0.0031, n 18), 95% CI -0.86 to -0.27. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.62 (p 0.0062, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.67 (p 0.0024, n 18). not the mix.
- skeptic
- leave-one-out range -0.74 to -0.61, sign flips 0; without severely affected donors -0.66 (p 0.0031, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for GP1BA in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts